Carvedilol Production Cost Reports

The report provides a detailed analysis essential for establishing a Carvedilol production plant. It encompasses all critical aspects necessary for Carvedilol production, including the cost of Carvedilol production, Carvedilol plant cost, Carvedilol production costs, and the overall Carvedilol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Carvedilol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Carvedilol is a non-selective beta-adrenergic blocker that is used to treat high blood pressure (hypertension), chronic heart failure, and left ventricular dysfunction following a heart attack. It works by blocking beta-1 and alpha-1 receptors, leading to decreased heart rate, vasodilation, and lowered blood pressure, which reduces the heart’s workload.

It is utilised to reduce mortality and hospitalisations in patients with heart failure and improve survival rates after heart attacks. Also, it is used for conditions like stable angina, atrial fibrillation, and ventricular arrhythmias. It is prescribed as part of combination therapy and helps improve blood flow and cardiac efficiency, which supports overall cardiovascular health. Its common side effects include dizziness, fatigue, low blood pressure, slow heart rate, diarrhoea, nausea, and weight gain.

The Carvedilol market is influenced by the rising prevalence of cardiovascular diseases. Its utilisation in managing hypertension and heart failure, an increasing geriatric population, along with expanding awareness about cardiovascular health, boosts its demand. The growing adoption of combination therapies and advances in drug formulations, and increased healthcare expenditure, further fuel its market demand. North America holds a significant market share because of high healthcare spending and disease prevalence, while emerging markets in the Asia Pacific are growing because of improving healthcare access and infrastructure. The industrial Carvedilol procurement is affected by adherence to strict regulatory approvals like WHO-GMP, USFDA, and EMA certifications that ensure product quality and safety.

Raw Material for Carvedilol Production

According to the Carvedilol production plant project report, the key raw materials used in the production of Carvedilol include (4-(2,3-Epoxy-1-propyl)Carbazole)-(2-(2-Methoxyphenoxy)Ethyl Amine)-Isopropanol.

Manufacturing Process of Carvedilol

The extensive Carvedilol production cost report consists of the following major industrial production process:

1. From 4-(2,3-Epoxy-1-propyl)Carbazole and 2-(2-Methoxyphenoxy)Ethyl Amine: The production of Carvedilol involves a condensation reaction. In this process, 4-(2,3-epoxy-1-propyl)carbazole is reacted with 2-(2-methoxyphenoxy)ethyl amine. This reaction is carried out by heating the two reactants in an organic solvent like isopropanol. After the reaction, the mixture is cooled, and water is added to quench the reaction. The crude product is then extracted using an organic solvent like dichloromethane. The organic layer is washed, dried, and concentrated. The crude Carvedilol is purified by crystallisation from ethyl acetate to get high-purity Carvedilol.

Carvedilol is a white to off-white crystalline solid with the molecular formula C24H26N2O4 and a molecular weight of 406.5 g/mol. It has a melting point of about 114.5 degree Celsius and is almost insoluble in water but freely soluble in solvents like dimethyl sulfoxide, methanol, and methylene chloride. It has high lipophilicity with an octanol/water partition coefficient (logP) of around 3.8. It has a carbazole ring and one chiral centre. It is rapidly absorbed with peak plasma concentrations reached within 1 to 2 hours post-oral administration. It produces active metabolites, and its elimination half-life ranges from 7 to 10 hours. It is highly protein-bound (~98%), lipophilic, and extensively distributed in body tissues. All these physical and chemical properties make it useful for treating cardiovascular conditions.